Parkinson’s Meds Accidentally Trigger Bacteria to “Eat” Levodopa
Parkinson’s Disease Treatment: The Gut Microbiome’s Unexpected Role For decades, levodopa has been the cornerstone of Parkinson’s disease treatment, often paired with catechol-O-methyltransferase inhibitors (COMT-Is) to maximize its effectiveness. However, a groundbreaking study reveals a surprising twist: COMT-Is may inadvertently undermine their own purpose by disrupting the gut microbiome and fueling the growth of bacteria … Read more